What is ImmunityBio, Inc.'s net change in cash?

ImmunityBio, Inc. (IBRX) reported net change in cash of $117.04M in Q1 2026.

How has ImmunityBio, Inc.'s net change in cash changed year-over-year?

ImmunityBio, Inc.'s net change in cash increased by 241.4% year-over-year, from -$82.77M to $117.04M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

ImmunityBio, Inc. IBRX Net Change in Cash

Net Change in Cash at other companies

Bristol-Myers SquibbBMY

-$635M-220%

Johnson & JohnsonJNJ

$1.98B-86.2%

Merck & Co.MRK

-$9.29B-103%

Gilead SciencesGILD

$65M+103%

Immunovant, Inc.IMVT

——

Kymera TherapeuticsKYMR

——

Other financials

Income statement

See full

Revenue$44.2M+168%

Gross profit$44.0M+167%

Operating income-$69.8M-8.3%

Net income-$632.8M-388%

EPS (diluted)-$0.62-313%

Balance sheet

See full

Cash & equivalents$205.2M+238%

Total debt$445.4M+32.2%

Total equity-$870.0M-47.1%

Total assets$646.6M+113%

Cash flow

See full

Operating cash flow-$75.4M+12.3%

CapEx$1.8M+58.4%

Free cash flow-$77.1M+11.4%

Valuation

See full

Market cap$7.71B+208%

Enterprise value$7.95B+187%

P/S54.7×-25.4×

Profitability

See full

Gross margin99.3%-0.5pp

Operating margin-185.4%-83.3pp

Net margin-606.2%-212pp

FCF margin-212%-95.8pp

Returns & leverage

See full

Return on equity-119.3%—

Debt / equity0.1×—

Current ratio6.7×+4.4×

Where this comes from

Reported directly by ImmunityBio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about ImmunityBio, Inc.'s net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ImmunityBio, Inc.'s net change in cash?: ImmunityBio, Inc. (IBRX) reported net change in cash of $117.04M in Q1 2026.
How has ImmunityBio, Inc.'s net change in cash changed year-over-year?: ImmunityBio, Inc.'s net change in cash increased by 241.4% year-over-year, from -$82.77M to $117.04M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.